Cushing Asset Management, LP Amarin Corp Plcuk Transaction History

Cushing Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $214,195 - $456,637	-58,845 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $98,573 - $170,337	20,622 Added 53.95%	58,845 $407,000
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $90,748 - $488,451	22,687 Added 146.03%	38,223 $153,000
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $215,795 - $359,813	15,536 New	15,536 $235,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.